Yerlikaya, Azmi <br/><br/>
Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.  [electronic resource] 

 -  Molekuliarnaia biologiia   
 - 859-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0026-8984 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzhydryl Compounds--pharmacology<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cysteine Proteinase Inhibitors--pharmacology<br/>Enzyme Activation--drug effects<br/>Eukaryotic Initiation Factor-2--metabolism<br/>Female<br/>HSP70 Heat-Shock Proteins--antagonists & inhibitors<br/>Heme Oxygenase-1--antagonists & inhibitors<br/>Humans<br/>Leupeptins--pharmacology<br/>Melanoma--metabolism<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors<br/>Protein Kinase C--metabolism<br/>Protoporphyrins--pharmacology<br/>Pyrazines--pharmacology<br/>Pyrrolidinones--pharmacology<br/>eIF-2 Kinase--metabolism<br/>p38 Mitogen-Activated Protein Kinases--metabolism